HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric S Clayman Selected Research

N- benzyloxycarbonyl- alanyl- alanyl- aspartyl- doxorubicin

10/2015Synthesis and Evaluation of a CBZ-AAN-Dox Prodrug and its in vitro Effects on SiHa Cervical Cancer Cells Under Hypoxic Conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric S Clayman Research Topics

Disease

2Neoplasms (Cancer)
10/2015 - 10/2015
1Breast Neoplasms (Breast Cancer)
10/2015
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2015
1Neoplasm Metastasis (Metastasis)
10/2015
1Reperfusion Injury
11/2014
1Venous Thromboembolism
05/2009

Drug/Important Bio-Agent (IBA)

1asparaginylendopeptidase (legumain)IBA
10/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015
1LigandsIBA
10/2015
1Peptide Hydrolases (Proteases)FDA Link
10/2015
1ProdrugsIBA
10/2015
1N- benzyloxycarbonyl- alanyl- alanyl- aspartyl- doxorubicinIBA
10/2015
1Chemokine ReceptorsIBA
10/2015

Therapy/Procedure

1Transplantation
11/2014
1Lipectomy (Liposuction)
05/2009
1Abdominoplasty
05/2009